Abstract
Pediatric sepsis is a burdensome public health problem. Assessing the mortality risk of pediatric sepsis patients, offering effective treatment guidance, and improving prognosis to reduce mortality rates, are crucial.
We extracted data derived from electronic medical records of pediatric sepsis patients that were collected during the first 24 hours after admission to the pediatric intensive care unit (PICU) of the Hunan Children's hospital from January 2012 to June 2014. A total of 788 children were randomly divided into a training (592, 75%) and validation group (196, 25%). The risk factors for mortality among these patients were identified by conducting multivariate logistic regression in the training group. Based on the established logistic regression equation, the logit probabilities for all patients (in both groups) were calculated to verify the model's internal and external validities.
According to the training group, 6 variables (brain natriuretic peptide, albumin, total bilirubin, D-dimer, lactate levels, and mechanical ventilation in 24 hours) were included in the final logistic regression model. The areas under the curves of the model were 0.854 (0.826, 0.881) and 0.844 (0.816, 0.873) in the training and validation groups, respectively.
The Mortality Risk Model for Pediatric Sepsis we established in this study showed acceptable accuracy to predict the mortality risk in pediatric sepsis patients.
Keywords: mortality, model, pediatric, sepsis
1. Introduction
Sepsis is a systemic inflammatory response syndrome that is triggered by infections caused by various pathogens. It can progress into severe sepsis and septic shock and become a focal and difficult issue in critical care medicine.[1,2] Children are at the highest risk for sepsis. Moreover, sepsis is a major cause of death in severe pediatric patients.[3,4]
The incidence of severe sepsis in infants was 5.16 per 1000 in United States.[5] The number of deaths among children <5 years old caused by sepsis worldwide was estimated to be 1 million (10% of all deaths) by the World Health Organization (WHO).[6] The in-hospital mortality associated with sepsis was 25% globally (irrespective of age), 24% in North America, Europe, and Australia/New Zealand, and 31% in Asia, Africa, and South America.[5] A retrospective observational study by Schlapbach et al[7] found that the mortality rates associated with sepsis and septic shock were 5.6% and 17.0%, respectively, in critically ill children in Australia and New Zealand. Consequently, sepsis poses a serious threat to human health, although recent research has shown that the mortality related to sepsis has been decreasing.[8]
Several pediatric intensive care units (PICU) have adopted the Pediatric Risk of Mortality (PRISM),[9,10] Pediatric Index of Mortality (PIM),[11,12] or Acute Physiology and Chronic Health Evaluation II score (APACHE II)[13] to assess the severity of sepsis in pediatric patients. However, these indices involve multiple systematic parameters and complex computation; this might not be ideal for the clinical use in pediatric sepsis patients, as their care typically requires quick clinical judgment. Moreover, the physiology of sepsis changes as the infant grows; therefore, general scoring systems such as APACHE II cannot precisely reflect the severity of sepsis in pediatric patients. PRISM or PIM are more suitable to assess the severity of critical pediatric illnesses; however, their indicators are not intended for sepsis, resulting in low specificity and accuracy.[12,14] Currently, the Mortality In Severe Sepsis in the Emergency Department (MISSED)[15] and the Sepsis Patient Evaluation in the Emergency Department (SPEED)[16] scores can be used to assess the mortality risk of sepsis patients; however, these scoring systems are primarily designed for adult patients.[17]
It is crucial to assess the mortality risk of pediatric sepsis patients, thereby supporting effective treatments, improving prognosis, and reducing mortality. Thus, a scoring model that can assess pediatric sepsis in a stratified manner is needed to guide physicians in the prompt treatment of these patients, in particular, during the initial stages of sepsis. Therefore, we develop a Mortality Risk Model for Pediatric Sepsis (MRMFPS) in this study.
2. Materials and methods
2.1. Study population
The medical records of pediatric sepsis patients who were admitted to the PICU of the Hunan Children's Hospital from January 2012 to June 2014 were retrospectively reviewed. The Hunan Children's hospital is the only comprehensive hospital for child illnesses in the Hunan province. It has 80 PICU beds and covers over 200 two-way referral hospitals. More than 80% of severe child patients in the Hunan province are admitted to this hospital. Therefore, patients are considered highly representative for pediatric patients with severe illnesses in the Hunan province.
We used the diagnostic criteria for sepsis of the Third International Consensus Definitions for Sepsis and Septic Shock.[18] Patients died within 4 hours of admission and those with missing data (age, sex, and prognosis) were excluded from our study.
To develop our risk model, 75% of the patients were randomly assigned to the training group and the remaining 25% to the validation group. The training group was used to build the model, and the validation group to evaluate it.
2.2. Data collection
According to diagnosis and exclusion criteria, study population was sorted out through reading hospital case files by the professionally trained medical staff. We collected data on patient demographics, clinical and physiologic parameters, as well as diagnosis and prognosis, retrospectively. To standardize data collection, the worst clinical and physiologic conditions were recorded within the first 24 hours of admission.
The independent variables in the mortality risk model included patient demographics (age and sex), vital signs (body temperature, heart rate, systolic blood pressure), infection-related indicators (leukocyte and platelet counts, procalcitonin [PCT], C-reactive protein [CRP] levels), and organ dysfunction-related indicators (bilirubin, creatinine, total bilirubin, D-dimer, brain natriuretic peptide [BNP] levels). All variables were measured with international standard methods, and EpiData3.0 was used to build a database. Double input by trained data entry clerks to ensure completeness and internal consistency.
2.3. Ethical statement
This study was approved by the Hunan Children's Hospital Ethics Review Committee. All investigations conformed to the principles outlined in the Declaration of Helsinki.
2.4. Statistical analysis
Statistical analysis was conducted using SPSS19.0. Descriptive results are presented as proportions (percentages), means (standard deviations, SD), or medians (interquartile ranges, IQR). Categorical variables were tested using the Chi-square test. Continuous variables were compared with the t-test and Mann–Whitney U test to detect differences in indicators of subgroups. In the training group, the mortality risk factors among pediatric sepsis patients were identified by conducting multivariate logistic regression (the forward step-wise method was used to screen variables; setting αin = 0.05, αout = 0.10). The variables for which P < .05 in univariate analysis were included in the multivariate logistic regression. In addition, the role of CRP as a potential biomarker for infection has been unclear since earlier studies showed inconsistent results. Therefore, the CRP was also included in the multivariate logistic regression.[20,21] The Hosmer–Lemeshow test was used to assess the goodness-of-fit of the logistic regression models. After the logistic regression equation was established, the logit probabilities of patients from both groups were calculated to verify internal and external validity. The model assessment indicators included the area under the curve (AUC), sensitivity, and specificity.
3. Results
3.1. Characteristics of the study participants
Of all patients admitted to the PICU during the study period, 846 met the criteria for sepsis. Of these, 49 (5.8%) were excluded due to a hospital stay of a duration of <4 hours and 9 (1.1%) due to missing data. In total, 788 children were included for final analysis; the response rate was 93.1%.
The median age of the study participants was 8.5 (IQR: 3.0–20.0) months, 65.2% were boys, and 210 (26.6%) died of sepsis. A total of 592 (75%) and 196 (25%) patients were assigned to the training and validation groups, respectively. We found no statistically significant differences for sex, age, length of PICU stay, mechanical ventilation in 24 hours, blood culture, cause of sepsis, and death between the 2 groups (Table 1).
Table 1.
3.2. Mortality Risk Model for Pediatric Sepsis (MRMFPS) in the training group
The univariate analysis showed that patient sex, mechanical ventilation in 24 hours, D-dimer levels, capillary refill time, prothrombin time (PT), the PaO2/FiO2 ratio, base excess, serum lactate, total bilirubin, serum total protein, alanine aminotransferase (ALT), urea nitrogen (BUN), creatinine (Cr), uric acid, myoglobin, PCT, BNP, and troponin levels showed significant associations with mortality caused by sepsis in the training group (Table 2).
Table 2.
We selected 19 variables to establish the multivariate logistic regression analysis (Table 3). As a result, 6 variables (BNP, albumin, total bilirubin, D-dimer, and lactate levels, as well as mechanical ventilation in 24 hours) were retained in the final logistic regression model (Table 4). The Hosmer–Lemeshow test results revealed an adequate goodness-of-fit for the regression model (χ2 = 6.766, P = .562).
Table 3.
Table 4.
3.3. Validity and diagnostic cut-off points of the MRMFPS
Based on the established logistic regression equation, the logit probabilities for all patients (in both groups) were calculated to verify the model's internal and external validities. The performance of our logistic regression equation for sepsis-related mortality risk prediction was examined for both groups using receiver operating characteristic (ROC) curves. The AUCs of our model were 0.854 (95% confidence interval [CI] 0.826–0.881) and 0.844 (95% CI 0.816–0.873) for the training and validation groups, respectively (Fig. 1). The optimal diagnosis cut-off point in the training group was logit probability = 0.22462, with a sensitivity of 0.857 and specificity of 0.701. For the validation group, the optimal diagnosis of cut-off point was logit probability = 0.189165 with a sensitivity of 0.873 and specificity of 0.677.
4. Discussion
We developed and validated a new in-hospital mortality risk model to assess the mortality risk of pediatric sepsis patients. In our study, 6 variables (BNP, albumin, total bilirubin, D-dimer, lactate levels, and mechanical ventilation in 24 hours) were included in the final Mortality Risk Model for Pediatric Sepsis (MRMFPS).
Our data are in agreement with those of previous studies.[22–25] The role of CRP and PCT as potential biomarkers for infection has been unclear since earlier studies showed inconsistent results.[20,21,26,27] In our study, we found no association between CRP and PCT and sepsis-related mortality in pediatric patients. This lack of association could have been because all study participants suffered from severe infections. CRP and PCT levels were shown not to be specific enough to assess the in-hospital mortality risk among pediatric sepsis patients.[28]
Lactate, an indicator of perfusion and oxygen metabolism, has been shown to have an important value in predicting the prognosis of severe sepsis/septic shock.[29] Increased levels of the N-terminal prohormone of BNP have been shown to be associated with a dysfunction of the cardiovascular system and systemic inflammation. It was shown that a BNP decline over time implied a favorable outcome and lower mortality risk.[30] High levels of D-dimer,[31] total bilirubin,[32] and low levels of albumin[33] were shown to be associated with mortality sepsis patients.
In 2003, Shapiro et al[17] first proposed that Mortality in Emergency Department Sepsis (MEDS) could evaluate the mortality risk in sepsis patients. Of 24 variables potentially related to in-hospital mortality, their model included the 9 parameters age, polypnea or anoxia, septic shock, blood platelet count, neutrophil ratio, lower respiratory infection, altered mental status, and being a nursing home resident. The model performed well with AUCs of 0.76 and 0.82 for the validation and training samples, respectively. Moreover, Alberti et al[34] established the Risk of Infection to Severe Sepsis and Shock Score that includes the 12 indicators total bilirubin levels, heart rate, serum Na+ concentration, platelet count, body temperature, systolic blood pressure, mechanical ventilation in 24 hours, pneumonia, peritonitis, gram-positive bacteria, aerobic gram-negative bacteria, and bacteremia. Moreover, they stratified sepsis into 4 levels by its score. However, the above-mentioned models included only patients aged ≥60 years and are therefore not likely to pediatric sepsis patients.
Regarding mortality risk prediction models for children, Okascharoen et al[35] used clinical data of 1870 newborns to establish an assessment scoring model for predicting delayed sepsis. Their model included the 6 parameters low blood pressure, abnormal body temperature, respiratory insufficiency, neutrophil count, abnormal blood platelet count, and catheterization of the umbilical vein. The ROC curve for neonatal sepsis patients was 0.80–0.85. However, this model was specifically designed use in newborns. In 2015, Bewersdorf et al[16] proposed a SPEED score to predict the 28-day mortality in sepsis patients admitted to the emergency department. The 8 indicators, immunosuppressed state, hypotension, hypothermia, hypoxemia, low hematocrit, elevated lactate levels, pneumonia, and acidosis were included in the model. However, this model was designed for adults and not children.
Regarding its application in the emergency department, our model is advantageous when compared to the MISSED[15] since fewer variables are included. Moreover, the variables included in the MRMFPS are easily available in clinical practice. Clinicians can easily stratify disease mortality risk and predict the risk of in-hospital mortality in children with sepsis. The MRMFPS showed a good predictive performance. However, validations for other populations are needed.
Our study has several limitations. First, the MRMFPS does not include indicators for the function of the nervous system, as these parameters were not included in patients’ electronic medical records. Therefore, our model should be further optimized since these indicators are widely used in clinical settings. Second, 5.8% of patients were excluded because they were admitted for less than 4 hours. These patients might more serious than the ones included in our study; this might affect the representativeness of the sample. Third, all study participants were recruited at the same hospital, reducing the representativeness of our study population. Further multi-center clinical studies with large sample sizes are needed to validate our results. Fourth, detection methods for clinical indicators might differ by hospitals; this could reduce the MRMFPS’ applicability to all clinical settings. Despite these limitations, MRMFPS showed acceptable accuracy to predict mortality risk in pediatric sepsis patients.
Footnotes
Abbreviations: ALT = alanine aminotransferase, APACHE II = Acute Physiology and Chronic Health Evaluation II score, AUC = area under the curve, BNP = brain natriuretic peptide, BUN = urea nitrogen, CI = confidence interval, Cr = creatinine, CRP = C-reactive protein, IQR = interquartile range, MISSED = Mortality in Severe Sepsis in the Emergency Department, MEDS = Mortality in Emergency Department Sepsis, MRMFPS = Mortality Risk Model For Pediatric Sepsis, OR = odds ratio, PCT = procalcitonin, PICU = pediatric intensive care unit, PIM = Pediatric Index of Mortality, PRISM = Pediatric Risk of Mortality, PT = prothrombin time, ROC = receiver operating characteristic, SD = standard deviation, SPEED = Sepsis Patient Evaluation in the Emergency Department.
MC and XL contributed equally to this study.
This work was supported by funding from the Ministry of Science and Technology of China (Grant 2012BAI04B01) and the Hunan Provincial Science and Technology Department (Grant 2010SK3076, 2013SK3218, 2016JJ3080).
The authors have no conflicts of interest to disclose.
References
- [1].Zimmerman JJ. Pediatric sepsis from start to finish. Pediatr Crit Care Med 2015;16:479–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [2].Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013;369:840–51. [DOI] [PubMed] [Google Scholar]
- [3].Riley C, Wheeler DS. Prevention of sepsis in children: a new paradigm for public policy. Crit Care Res Pract 2012;2012:437139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [4].Weiss SL, Fitzgerald JC, Pappachan J, et al. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med 2015;191:1147–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5].Watson RS, Carcillo JA, Linde-Zwirble WT, et al. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003;167:695–701. [DOI] [PubMed] [Google Scholar]
- [6].Edmond K, Zaidi A. New approaches to preventing, diagnosing, and treating neonatal sepsis. PLoS Med 2010;7:e1000213. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7].Schlapbach LJ, Straney L, Alexander J, et al. Mortality related to invasive infections, sepsis, and septic shock in critically ill children in Australia and New Zealand, 2002–2013: a multicentre retrospective cohort study. Lancet Infect Dis 2015;15:46–54. [DOI] [PubMed] [Google Scholar]
- [8].Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303–10. [DOI] [PubMed] [Google Scholar]
- [9].Bilan N, Galehgolab BA, Emadaddin A, et al. Risk of mortality in pediatric intensive care unit, assessed by PRISM-III. Pakistan J Biol Sci 2009;12:480–5. [DOI] [PubMed] [Google Scholar]
- [10].Goncalves JP, Severo M, Rocha C, et al. Performance of PRISM III and PELOD-2 scores in a pediatric intensive care unit. Eur J Pediatr 2015;174:1305–10. [DOI] [PubMed] [Google Scholar]
- [11].Slater A, Shann F, Pearson G. Pediatric Index of Mortality (PIM) Study Group. PIM 2: a revised version of the Pediatric Index of Mortality. Intensive Care Med 2003;29:278–85. [DOI] [PubMed] [Google Scholar]
- [12].Shime N, Kawasaki T, Saito O, et al. Incidence and risk factors for mortality in paediatric severe sepsis: results from the national paediatric intensive care registry in Japan. Intensive Care Med 2012;38:1191–7. [DOI] [PubMed] [Google Scholar]
- [13].Lee H, Lim CW, Hong HP, et al. Efficacy of the APACHE II score at ICU discharge in predicting post-ICU mortality and ICU readmission in critically ill surgical patients. Anaesth Intensive Care 2015;43:175–86. [DOI] [PubMed] [Google Scholar]
- [14].Paridon BMV, Sheppard C, Garcia GG, et al. Timing of antibiotics, volume, and vasoactive infusions in children with sepsis admitted to intensive care. Crit Care 2015;19:1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [15].Sivayoham N, Rhodes A, Cecconi M. The MISSED score, a new scoring system to predict Mortality In Severe Sepsis in the Emergency Department: a derivation and validation study. Eur J Emerg Med 2014;21:30–6. [DOI] [PubMed] [Google Scholar]
- [16].Bewersdorf JP, Hautmann O, Kofink D, et al. The SPEED (sepsis patient evaluation in the emergency department) score: a risk stratification and outcome prediction tool. Eur J Emerg Med 2015;24:170–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [17].Shapiro NI, Wolfe RE, Moore RB, et al. Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule. Crit Care Med 2003;31:670–5. [DOI] [PubMed] [Google Scholar]
- [18].Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016;315:801–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [19].Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005;6:2–8. [DOI] [PubMed] [Google Scholar]
- [20].Magrini L, Gagliano G, Travaglino F, et al. Comparison between white blood cell count, procalcitonin and C reactive protein as diagnostic and prognostic biomarkers of infection or sepsis in patients presenting to emergency department. Clin Chem Lab Med 2014;52:1465–72. [DOI] [PubMed] [Google Scholar]
- [21].Jiang L, Feng B, Gao D, et al. Plasma concentrations of copeptin, C-reactive protein and procalcitonin are positively correlated with APACHE II scores in patients with sepsis. J Int Med Res 2015;43:188–95. [DOI] [PubMed] [Google Scholar]
- [22].Holder AL, Gupta N, Lulaj E, et al. Predictors of early progression to severe sepsis or shock among emergency department patients with nonsevere sepsis. Int J Emerg Med 2016;9:10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [23].Alder MN, Lindsell CJ, Wong HR. The pediatric sepsis biomarker risk model: potential implications for sepsis therapy and biology. Expert Rev Anti Infect Ther 2014;12:809–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [24].Guaricci AI, Santoro F, Paoletti Perini A, et al. Correlations between NT-proBNP, outcome and haemodynamics in patients with septic shock. Acta Cardiol 2015;70:545–52. [DOI] [PubMed] [Google Scholar]
- [25].Artigas A, Wernerman J, Arroyo V, et al. Role of albumin in diseases associated with severe systemic inflammation: Pathophysiologic and clinical evidence in sepsis and in decompensated cirrhosis. J Crit Care 2016;33:62–70. [DOI] [PubMed] [Google Scholar]
- [26].Lee SH, Chan RC, Wu JY, et al. Diagnostic value of procalcitonin for bacterial infection in elderly patients - a systemic review and meta-analysis. Int J Clin Pract 2013;67:1350–7. [DOI] [PubMed] [Google Scholar]
- [27].Sano H, Kobayashi R, Iguchi A, et al. Risk factors for sepsis-related death in children and adolescents with hematologic and malignant diseases. J Microbiol Immunol Infect 2015;50:232–8. [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
- [28].Hisamuddin E, Hisam A, Wahid S, et al. Validity of C-reactive protein (CRP) for diagnosis of neonatal sepsis. Pakistan J Med Sci 2015;31:527–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [29].Yoo JW, Lee JR, Jung YK, et al. A combination of early warning score and lactate to predict intensive care unit transfer of inpatients with severe sepsis/septic shock. Korean J Int Med 2015;30:471–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [30].Papanikolaou J, Makris D, Mpaka M, et al. New insights into the mechanisms involved in B-type natriuretic peptide elevation and its prognostic value in septic patients. Crit Care (London, England) 2014;18:R94. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [31].Rodelo JR, De la Rosa G, Valencia ML, et al. D-dimer is a significant prognostic factor in patients with suspected infection and sepsis. Am J Emerg Med 2012;30:1991–9. [DOI] [PubMed] [Google Scholar]
- [32].Patel JJ, Taneja A, Niccum D, et al. The association of serum bilirubin levels on the outcomes of severe sepsis. J Intensive Care Med 2015;30:23–9. [DOI] [PubMed] [Google Scholar]
- [33].Wang B, Chen G, Cao Y, et al. Correlation of lactate/albumin ratio level to organ failure and mortality in severe sepsis and septic shock. J Crit Care 2015;30:271–5. [DOI] [PubMed] [Google Scholar]
- [34].Alberti C, Brun-Buisson C, Chevret S, et al. Systemic inflammatory response and progression to severe sepsis in critically ill infected patients. Am J Respir Crit Care Med 2005;171:461–8. [DOI] [PubMed] [Google Scholar]
- [35].Okascharoen C, Sirinavin S, Thakkinstian A, et al. A bedside prediction-scoring model for late-onset neonatal sepsis. J Perinatol 2005;25:778–83. [DOI] [PubMed] [Google Scholar]